Although new anticancer treatments have increased the life expectancy, they are associated with treatment-related comorbidities. One of the side effects of these treatments is cardiotoxicity. Although it is dependent on the multiple factors, detection and management of the cardiac problems are crucial to avoid morbidity and mortality.
This article provides excerpts of the guideline designed by the European Society For Medical Oncology. The incidence of cardiac diseases is dependent on various factors such as type of drug, dose administered during each cycle, route of administration, cumulative dose, schedule of administration, and combination of other cardiotoxic drugs or radiotherapy along with patient-related factors like age, presence of cardiovascular disease (CVD) risk factor, history of CVD, age etc. The cardiac injuries are mostly related with curable malignancies irradiated at…
